Effectiveness of prebiotics and probiotics in treating recurrent vaginitis in Indian women
Résumé fourni par la source
Background: Recurrent vaginitis refers to the occurrence of vaginitis 3 or more times in a year. Studies have highlighted the potential benefits of prebiotics and probiotics in vaginitis treatment.Aim and Objective: To evaluate the efficacy of prebiotics & probiotics in recurrent vaginitis in Indian women.Materials and Methods: 100 women with recurrent vaginitis were randomized into two groups. Study group received pre & probiotics capsule (Bifilac capsule) twice daily for 8 weeks along with standard therapy. Control group received standard therapy alone. The standard therapy comprised of antibiotics & antifungals. Duration of the study was 24 weeks with 8 weeks of Intervention and 16 weeks of follow up. Reduction in symptoms and recurrence rate were the primary end points. Causative organisms and the restoration of vaginal pH were evaluated.Results: At 8 weeks, vaginitis symptoms were reduced in 76 % of subjects in study group as compared to 48 % in control group (P = 0.003). After 24 weeks, there was a significant reduction in the recurrence rate observed in the study group as compared to control group (86 % vs 62 %, P = 0.006). Candida species accounted for 64 % of cases of vaginitis. A higher proportion of women in the study group (98 %) achieved restoration of acidic pH in the vagina as compared to the control group (74 %) (P < 0.001).Conclusion: The addition of pre & probiotics (Bifilac capsule) to the standard treatment resulted in better clinical outcomes in women suffering from recurrent vaginitis.Keywords: Probiotics, Prebiotics, Recurrent vaginitis, Bifilac.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Effectiveness of prebiotics and probiotics in treating recurrent vaginitis in Indian women
- Date Crossref
- 04/02/2026
- Éditeur
- IP Innovative Publication Pvt Ltd
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.
Institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.